The human body functions in amazing ways to keep foreign invaders from entering. Upon detection, immune cells act to neutralize and remove pathogens. They tag them as dangerous, endocytosis, phagocytosis, and pinocytosis. Blood proteins called antibodies essentially sniff out specific antigens, discerning between self and non-self particles. Then, they appropriately dispose of them. Unfortunately, the body gets mixed… Read more »
Posts Categorized: Programs & Events
Proteins are one of four macromolecule building blocks that are necessary for any form of life. That’s why being able to analyze proteins with a protein assay is crucial in both research and diagnosis. Total protein assay kits can be used to determine the total protein concentration of a sample. To help you choose the… Read more »
ITSI-Biosciences, wins local Small Business Association Exporter of the Year Awards. Read full press release article
ProDM – A Colorimetric Kit for Rapid Monitoring and Standardization of Tryptic Digestion for Improved and Reproducible Shotgun Proteomics was presented at the US HUPO 9th Annual Conference March 10 – 13, 2013. See poster
iTRAQ detects eEF1A1 as a candidate biomarker for Metastatic Progression of Prostate Cancer ITSI-Biosciences’ latest newsflash publication, “iTRAQ detects eEF1A1 as a candidate biomarker for Metastatic Progression of Prostate Cancer” discusses how PSA is plagued with controversies and is unreliable because of its potential to provide false positive and false negative results. Hence additional biomarkers… Read more »
ITSI-Biosciences has renewed its Blanket Purchase Agreement (BPA#: HHSN263200900168B) with the NIH Our products and services are customized for researchers interested in biomarker discovery/validation and protein expression monitoring using human and non-human models. We strive to deliver the best products and quality results to you on a timely basis and within your budget. We would… Read more »
Read full article
Proteomics on Formalin-Fixed Parafin-Embedded Tissues ITSI-Biosciences’ latest newsflash publication, “Proteomics on Formalin-Fixed Parafin-Embedded Tissues” discusses how Formalin-Fixed Paraffin Embedded Tissues (FFPE) are commonly used in healthcare to preserve tissues from a wide variety and different stages of a disease. However formalin cross links the protein and poses a great obstacle for downstream proteomics application. Download… Read more »
ITSI-Biosciences’ latest application note, “ITSIPrep Kits for Two Dimensional Difference in Gel Electrophoresisâ€ discusses how to: 1) Achieve great results in 2D-DIGE experiments. 2) Streamline and standardize the up-stream sample preparation steps including protein isolation, fractionation, precipitation and depletion. 3) Avoid the use of poor quality reagents and inadequate protocols which results to poor quality… Read more »
ITSI – Bioscience www.itsibio.com has announced the receipt of a $100,000 Small Business Innovation Research (SBIR) Phase 1 grant from the National Cancer Institute. The grant will support ITSIBIO’s ongoing blood-based breast cancer detection biomarker program that promises to provide an alternate method for earlier detection and accurate classification of breast malignancies. At the moment… Read more »
Itsibio representatives visit GE Healthcare, Piscataway NJ. Meet with Andy Bertera, Head of Marketing, Gene & Protein Discovery.
Itsibio attends Bio 2005, meets with potential partners from around the world.
Itsibio representative visits Hospital das Clinicas de Porto Alegre, Universidade Federal do Rio Grande Sul, Porto Alegre, Brazil. Presents seminar “Advances in Tissue Banking & Biomedical Research” and meets with Prof Dr. Carlos Menke and top faculty members to discuss partnership.
Mr. Joseph Burke, Director, Americas, So. Africa, Mid. East & Oceania Grp., PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Silvia Alonso, Senior Trade Specialist for PA in Mexico visit itsibio corporate headquarters/laboratory.
Itsibio attends American Society of Breast Disease (ASBD) annual meeting (April 13-16 2005) in Las Vegas, NV. Itsibio representative serves on the Outreach and special populations committee and is a member of the Expert working group on risk assessment of the ASBD.
Itsibio representative visits University of Nigeria, Nsukka, Nigeria and presents seminar “Emerging high throughput technologies and complex disease research” Meets with Director, University Resource Foundation, Provost, University of Nigeria Teaching Hospital, Chief Medical Director, University of Nigeria Teaching Hospital and other senior faculty and university administrators to discuss partnership between both organizations.
Itsibio representative visits the Institute of Advanced Medical Research & Training, University of Ibadan, Nigeria and University College Hospital, Ibadan, Nigeria. Presents a seminar &;Advances in High throughput Biomedical Research & Personalized Medicine. Meets with Prof E. Bababunmi, Prof. Francis AA Adeniyi and Prof. Idowu Yinka and other senior faculty members to discuss partnership between both… Read more »
Itsibio representative attends the launching of the Nigerian Army Medical Corps/School (NAMC/S) rollback malaria program. Meets with the Honorable Minister of State for defense Dr. Roland Oritsejafor, Lt. Gen ML Agwai (Chief of Army Staff) and Maj. Gen B. E. Abang (Commandant NAMC/S).
Itsibio representative visits and presents a seminar; Application of emerging high throughput technologies in complex disease research; at the College of Pharmacy, University of Houston, TX. Meets with Dean Sunny Ohia and senior faculty.
Itsibio and Asterand Inc. sign collaboration agreement.
Itsibio formally opens ultra-modern laboratory for genomics and proteomics research and provision of bioanalytical services.